Browse the evidence

Resting metabolic rate (RMR) decreased during the caloric restriction (CR) intervention compared to baseline.

Practitioners should note that caloric restriction can lead to a decrease in resting metabolic rate over time.

There was no evidence for long-term metabolic adaptation to weight loss in assessments of resting metabolic rate.

Practitioners should understand that weight loss may not lead to long-term changes in resting metabolic rate.

Low birth weight (< 5.5 lb) is associated with an increased risk of hypertension (age-adjusted odds ratio of 1.26) and diabetes mellitus (age-adjusted odds ratio of 1.75).

Practitioners should consider birth weight as a potential risk factor for hypertension and diabetes in adult patients.

High birth weight (≥ 10.0 lb) is associated with an increased risk of obesity (age-adjusted odds ratio of 2.08).

Practitioners should be aware that high birth weight may increase the risk of obesity in adult patients.

Each 5-unit increment in BMI was associated with a 20% increased risk of early-onset CRC (RR 1.20).

Weight management strategies may be important for reducing early-onset CRC risk.

The association between glycemic load and cardiovascular events was similar to that of glycemic index among participants with cardiovascular disease at baseline, but not significant among those without preexisting cardiovascular disease.

Glycemic load may be a relevant factor for cardiovascular risk in individuals with existing conditions, but less so for those without.

Individuals with high diastolic blood pressure benefited more from bariatric surgery than those with low diastolic blood pressure.

Bariatric surgery may be particularly beneficial for obese patients with high diastolic blood pressure.

Understanding the weight loss effect of SGLT2 inhibitors can aid clinicians in optimal treatment decision-making.

Clinicians should consider weight loss effects when prescribing SGLT2 inhibitors.

Bariatric surgery was associated with a lower incidence of cardiovascular mortality, with an adjusted hazard ratio of 0.35.

Bariatric surgery may lead to lower rates of death from cardiovascular causes in this population.

Bariatric surgery was associated with a lower incidence of the secondary outcome of 3-component MACE, with an adjusted hazard ratio of 0.66.

Bariatric surgery may reduce the risk of combined cardiovascular events in this patient group.

Intakes of saturated fatty acids (SFAs), trans-fatty acids, animal monounsaturated fatty acids (MUFAs), α-linolenic acid, and arachidonic acid were associated with higher mortality.

Reducing intake of these fats may lower mortality risk.

Resting ATP levels were lower after LIT with OCC compared to before training.

Low-intensity resistance training with vascular occlusion may lead to lower ATP levels in muscles, indicating increased energy demand.

Corpulent phenotypes with subcutaneous fat accumulation display low cardiovascular mortality.

Practitioners should consider the protective effects of subcutaneous fat against cardiovascular mortality.

Reimposing calorie restriction after weight loss had little effect, except that fasting plasma glucose and HGP improved slightly further.

Calorie restriction may have limited benefits after significant weight loss in obese NIDDM patients.

Alterations in SNS effects on metabolism have been implicated in the development and maintenance of obesity.

Recognizing the role of SNS alterations can inform obesity treatment approaches.

Both exercise training and rosiglitazone decreased liver triacylglycerol content.

Both exercise and rosiglitazone may be beneficial for reducing liver fat content.

The risk of cardiovascular events or death increases progressively from normoglycaemic to newly diagnosed diabetics.

Interventions aimed at improving glucose metabolism may reduce cardiovascular risk across different populations.

Psychotropic drug-related weight gain (PDWG) is highly associated with non-initiation, discontinuation, and dissatisfaction with psychiatric drugs.

Practitioners should be aware of the impact of PDWG on patient adherence to psychiatric medications.

There is significant variation in metabolic rate in humans, independent of differences in body size, body composition, age, and gender.

Practitioners should consider individual metabolic rates when assessing health and nutrition.

The dietary glycemic load did not influence chronic adaptations in glucose-insulin dynamics beyond what was associated with weight loss.

Focus on weight loss rather than dietary glycemic load for improving glucose-insulin dynamics.

SMR in stage 3 sleep was significantly lower than in stage 2 and rapid eye movement sleep.

Recognizing the metabolic differences across sleep stages can inform sleep hygiene practices.

Resting metabolic rate (RMR) was similar in Caucasians and Pimas but decreased significantly after propranolol infusion in Caucasians.

Practitioners should consider ethnic differences in metabolic responses to medications like propranolol.

The factors accounting for the variability of NEAT can be categorized as environmental or biological.

Recognizing these factors can aid in creating targeted strategies to enhance NEAT.

The means for sleeping and resting metabolic rates, thermic effect of food, and spontaneous physical activity were unchanged between diets.

Metabolic rates and activity levels are not significantly affected by high-fat versus high-carbohydrate diets.